发明名称 COMPOSITIONS AND METHODS FOR MINIMIZING OR REDUCING AGONIST-INDUCED DESENSITIZATION
摘要 Methods and compositions are provided for preventing or reversing loss of the therapeutic effect of a drug, where the loss is associated with the repeated administration of the drug to a patient. The method includes administering to the patient a dopamine receptor agonist or partial agonist or a drug that increases the extracellular level of dopamine by enhancing release of dopamine, decreasing the removal of dopamine from the extracellular space, enhancing the synthesis of dopamine within the brain, or decreasing metabolic degradation of dopamine; and also administering to the patient an opioid receptor antagonist in an ultra-low dose amount, wherein the ultra-low dose amount is effective to prevent or reverse loss of therapeutic effects associated with the repeated administration of the drug to the patient. The methods are useful for various treatments, including treating Parkinson's Disease, Restless Leg Syndrome, depression, schizophrenia, psychostimulant drug abuse, or attention deficit disorder.
申请公布号 US2010168119(A1) 申请公布日期 2010.07.01
申请号 US20090603235 申请日期 2009.10.21
申请人 PHARMORX, INC. 发明人 BEAR DAVID M.;KESSLER ROBERT M.
分类号 A61K31/4985;A61K31/135;A61K31/404;A61K31/428 主分类号 A61K31/4985
代理机构 代理人
主权项
地址